Navigation Links
Pfizer Global Manufacturing Announces Plans to Reconfigure Its Global Plant Network
Date:5/18/2010

ical to our efforts to remain competitive so that we can continue to meet patient needs and expand the access and affordability of our medicines," said Pfizer Global Manufacturing President Nat Ricciardi.

"Nevertheless, today's announcement is very difficult to make because of its impact on our colleagues," Mr. Ricciardi added.  "We have a tremendous global workforce and some of the best manufacturing facilities in the industry.  But we must continue to adjust to the fast-changing and extremely competitive environment in which we operate.  That means realigning our network and reducing our manufacturing capacity so that we can position Pfizer for the next phase of growth across biopharmaceuticals and our diversified business portfolio."

The announcement is the culmination of an intense half-year evaluation of sites that manufacture aseptic (injectable), solid-dose, and biotechnology medicines, as well as consumer healthcare products.

Pfizer plans to discontinue manufacturing operations over the next 18 months to five years at three solid-dose sites that manufacture tablets and capsules: Caguas in Puerto Rico; Loughbeg in Ireland; and Rouses Point, N.Y., in the United States.  (Wyeth had previously announced in 2005 that it would exit and sell the Rouses Point site.)

The company also plans to phase out pharmaceutical solid-dose manufacturing at Guayama, Puerto Rico, and that site will expand its Consumer Healthcare operations.

Two aseptic facilities that make sterile injectable medicines are targeted for exit: Dublin, Ireland; and
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Anavex comments on failure of Pfizer and Medivations Alzheimers investigational drug Dimebon during Phase 3 clinical trials
2. Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting
3. Pfizer Global R&D Presents 2008 Top Intermediates CMO Award to Asymchem
4. GSK and Pfizer Innovative Agreement Creates Specialist HIV Company
5. Lakewood-Amedex, Inc. Appoints William J. Robison, Former Executive Vice President of Pfizer, as Board Member
6. MannKind Agrees with Pfizer on the Purchase of Frankfurt Insulin Manufacturing Plant
7. JMAR Technologies' Chief Scientist Invited by Pfizer Inc. to Speak at IFPAC -- BioSentry Makes Strides in Pharma Market
8. Hovione Buys Pfizers Loughbeg API Facility
9. WWMR Announces Pain Clinic Physicians Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals
10. Stem Cell Sciences Signs Service Agreement With Pfizer to Provide Access to Proprietary Technologies and Methods
11. WuXi PharmaTech Signs New Collaboration Agreement With Pfizer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Deep Knowledge Ventures last week ... ‘Commercialising Longevity Research’ and welcomed a host of ... Bioscience Innovation Center for the event, organised by ... Ltd. The meeting highlighted the need for both ... age-related disease, as well as the crucial role ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 Unraveling life’s ... together. The Archer Family purchased a DNA ... DNA, but ended up with a lifetime of memories, ... within the family members’ DNA genuinely brought the family ... to search deeper into genetic history and prior to ...
(Date:7/10/2014)... EvoDerma ’s NOOME Anti-Aging Motion has been upgraded for ... a second treatment cup to help prevent and smooth skin ... thinner on the edges for a softer contact with the ... surfaces on the face, neck and décolleté. Choose to use ... such as the cheeks and neck, or opt for the ...
(Date:7/10/2014)... July 10, 2014 On July ... Medvedev , presented Russia,s first ... . The Company is developing a unique project called ... BIOCAD develops a number of innovative drugs based on ... The ceremony took place at the International Exhibition "Innoprom ...
Breaking Biology Technology:DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 4Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 5Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2
... Ron Van Beek, president and CEO of Van Beek ... for dogs and cats, available exclusively through veterinarians. ... supplement containing both probiotics and prebiotics that work together ... dog,s or cat,s GI tract.  Van Beek Natural Science,s ...
... Pharmaceuticals, Inc. (Nasdaq: AUXL ), a specialty biopharmaceutical ... year 2010 on Thursday, February 10, 2011 before the opening ... a conference call that day at 10:00 a.m. ET to ... year 2010.  The presentation slides to be used during the ...
... Barrow Neurological Institute scientist on the thermoregulatory effects of a ... the cover story in the Feb. 2 issue of the ... an international team led by Andrej Romanovsky, MD, PhD, Director ... a part of St. Joseph,s Hospital and Medical Center. ...
Cached Biology Technology:Van Beek Natural Science Announces New Synacore Digestive Support Product 2Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2010 Results and Conduct Conference Call on Thursday, February 10, 2011 2Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2010 Results and Conduct Conference Call on Thursday, February 10, 2011 3Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2010 Results and Conduct Conference Call on Thursday, February 10, 2011 4Barrow TRPV1 research highlighted in Journal of Neuroscience 2
(Date:7/10/2014)... Fingerprint Cards, (FPC,s) new mobile touch sensor FPC1021 ... Top 5 smartphone OEM has selected FPC1021 for a flagship ... 2014.   FPC is proud to announce this ... a planned date for the start of mass production in ... of 3 million units. The Chinese OEM wants to remain ...
(Date:7/10/2014)... July 8, 2014 Fingerprint ... new design win (DW). An Asian OEM has selected FPC1021 ... production start in August 2014.   FPC is ... which has a planned date for start of mass production ... order of SEK 5M, for delivery in the first half ...
(Date:7/10/2014)... 9, 2014 The widespread adoption of ... part by meaningful use and related federal programs, ... with laboratory information. Now, more than ever, pathologists ... clinical informatics in order to deliver high quality ... the educational needs of pathologists in this evolving ...
Breaking Biology News(10 mins):FPC Wins DW for 1021 Touch Sensor for Flagship Smartphone from Chinese Top 5 Smartphone OEM 2FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM 2New Clinical Informatics Curriculum Prepares Future Pathologists 2New Clinical Informatics Curriculum Prepares Future Pathologists 3New Clinical Informatics Curriculum Prepares Future Pathologists 4
... release is available in French . ... a microscope. Now more than ever, municipal builders need to ... projects like the Turcot interchange lead Montrealers to wonder if ... New research from Concordia University gives us hope that this ...
... (Boston) A study led by researchers at Boston ... that connect a variety of diseases associated with inflammation. ... are cells largely responsible for inflammation, researchers have shown ... decrease the inflammatory response associated with diseases such as ...
... Researchers from Ludwig-Maximilians-Universitaet (LMU) in Munich identify a ... gene and prevents stress-induced neuronal cell death. ... and the second most common neurodegenerative disease after ... of dopamin-producing neurons in the substantia nigra, a ...
Cached Biology News:Towards more sustainable construction 2Mechanisms regulating inflammation associated with type 2 diabetes, cancer identified 2Parkinson's disease: Parkin protects from neuronal cell death 2